{"id":19963,"date":"2019-03-19T00:31:01","date_gmt":"2019-03-19T00:31:01","guid":{"rendered":"https:\/\/positivelysharing.wordpress.com\/?p=19963"},"modified":"2019-03-19T00:31:01","modified_gmt":"2019-03-19T00:31:01","slug":"gilead-increases-hiv-drug-prices-by-4-9-in-us","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2019\/03\/19\/gilead-increases-hiv-drug-prices-by-4-9-in-us\/","title":{"rendered":"Gilead increases HIV drug prices by 4.9% in US"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><p><img decoding=\"async\" src=\"https:\/\/www.countynewscenter.com\/wp-content\/uploads\/PrEP1_1200px.jpg\" \/>Gilead Sciences increased the U.S. prices of its top six antiviral drugs that treat HIV by 4.9 percent, according to financial and investment news site <em><a href=\"https:\/\/www.barrons.com\/articles\/gilead-sciences-increased-some-drug-prices-why-thats-good-news-and-bad-news-for-the-stock-51552926390\">Barron&#8217;s.<\/a><\/em><\/p>\n<p>The drugs, Atripla, Biktarvy, Descovy, Genvoya, Odefsey and Truvada, account for 95 percent of the revenue from Gilead&#8217;s HIV pipeline.\u00a0 <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/gilead-increases-hiv-drug-prices-by-4-9-in-us.html\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>Gilead Sciences increased the U.S. prices of its top six antiviral drugs that treat HIV by 4.9 percent, according to financial and&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-19963","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-hiv"},"jetpack_featured_media_url":"","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/19963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=19963"}],"version-history":[{"count":0,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/19963\/revisions"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=19963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=19963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=19963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}